On the HCPLive psoriatic arthritis page, resources on the topics of medical news and expert insight into PsA can be found. Content includes articles, interviews, videos, podcasts, and breaking news on arthritis, and more.
May 17th 2024
An analysis of more than 1800 adults with psoriatic arthritis found more than 20% of patients report widespread pain, with 10% meeting fibromyalgia criteria.
Long-Term Opioid Use Observed for 1 in 5 with Rheumatic or Musculoskeletal Disorders
May 17th 2023An analysis of the Clinical Practice Research Datalink provides an overview of trends and prevalence of long-term opioid use among patients with 1 of 6 rheumatic or musculoskeletal diseases using 3 definitions of long-term opioid use.
Concurrent Management of Inflammatory Bowel Disease and Psoriatic Arthritis
May 9th 2023Dr David Hudesman, Dr Jordan Axelrad, and Dr Jose Scher discuss strategies for managing coexisting inflammatory bowel disease and psoriatic arthritis and highlight the importance of a multidisciplinary approach to providing comprehensive care.
Study Finds Idiopathic Inflammatory Rheumatic Diseases are Linked with More Sick Leave
May 8th 2023According to the study, these findings can inform policy decisions and assist in developing interventions aimed at reducing absenteeism and promoting the productivity of individuals with idiopathic inflammatory rheumatic diseases.
Tofacitinib-Treated Women With PsA Less Likely to Achieve MDA
At month 3, patients treated with tofacitinib achieved higher rates of ACR20/50, MDA, and PASI75 in both sexes when compared with the placebo. However, female patients were less likely to achieve MDA when compared with males.
Soumya Chakravarty, MD, PhD: Guselkumab Demonstrates Long-Term Efficacy in Treating PsA
Soumya Chakravarty, MD, PhD, discussed the results of the DISCOVER-1 and DISCOVER-2 studies that evaluated the long-term efficacy of guselkumab for the treatment of adult patients with active psoriatic arthritis.